novartis europharm limited - asciminib hydrochloride - leikēmija, mielogēns, hronisks, bcr-abl pozitīvs - antineoplastiski līdzekļi - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)